{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T23:25:46Z","timestamp":1649201146924},"reference-count":0,"publisher":"Japanese Society of Toxicology","issue":"Special Issue 2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2009]]},"DOI":"10.2131\/jts.34.sp327","type":"journal-article","created":{"date-parts":[[2009,7,2]],"date-time":"2009-07-02T06:00:52Z","timestamp":1246514452000},"page":"SP327-SP329","source":"Crossref","is-referenced-by-count":2,"title":["Essentials for starting a pediatric clinical study (4): Clinical pediatric safety planning based on preclinical toxicity studies and pediatric pharmacovigilance guidance"],"prefix":"10.2131","volume":"34","author":[{"given":"Neha","family":"Sheth","sequence":"first","affiliation":[{"name":"Safety and Risk Management, Pfizer, Inc."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"898","container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jts\/34\/Special_\/34_Special__SP327\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:26:40Z","timestamp":1620962800000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jts\/34\/Special_\/34_Special__SP327\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":0,"journal-issue":{"issue":"Special Issue 2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.34.sp327","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009]]}}}